Cynata Therapeutics Ltd (ASX:CYP) has been granted a trading halt by the ASX, pending details regarding a commercial partnering transaction with respect to the company’s proprietary Cymerus™ stem cell technologies.
The halt will remain in place until the opening of trade on Tuesday 6th September 2016, or earlier if an announcement is made to the market.
Proactive Investors Australia is the market leader in producing news, articles and research reports on ASX emerging companies with distribution in Australia, UK, North America and Hong Kong / China.